Lerasan, Elsa L.

HRN: 22-58-49  Sex: Female

Patient Encounter


AMS Audit List

Audit Date
Antimicrobial
Start Date
End Date
Route
Dose
Frequency
Indication Documented
02/10/2023
CEFTAZIDIME 1GM (VIAL)
02/10/2023
02/17/2023
IV
1 Gram
Q8
Cap-mr; Copd In Ae
Waiting Final Action 
02/10/2023
AZITHROMYCIN 500MG TABLET (TAB)
02/10/2023
02/16/2023
PO
500 MG
OD
Cap-mr; Copd In Ae
Waiting Final Action 
02/17/2023
AZITHROMYCIN 500MG TABLET (TAB)
02/17/2023
02/18/2023
PO
500mg
2 More Days
Pneumonia
Waiting Final Action 

AMS Audit Form


Start Date: End Date:

Indication:

              

Type of Infection:

                             

           

Compliance to guidelines:



Initial appropriateness:



 If inappropriate:

           

Final appropriateness:



 If inappropriate:

              

Overall appropriateness: